Product image of Hedelix S.A (Extract Of Hedera Helix Folium (2.2 – 2.9 : 1), Extracting Agent: Ethanol 50% (V / V), Propylene Gly) supplied by GNH India

Hedelix S.A

Active Ingredient:
Extract Of Hedera Helix Folium (2.2 – 2.9 : 1), Extracting Agent: Ethanol 50% (V / V), Propylene Gly
Origin:
EU

Hedelix S.A (Extract Of Hedera Helix Folium (2.2 – 2.9 : 1), Extracting Agent: Ethanol 50% (V / V), Propylene Gly)

Extract of Hedera helix folium, the active ingredient in Hedelix S.A, is a herbal presented as a liquid extract for oral use. It is traditionally employed to support respiratory health, particularly in conditions characterized by mucus accumulation and bronchial irritation. The preparation contains a standardized ratio of 2.2–2.9 : 1 plant material to ethanol 50 % (v/v) with propylene glycol as a solubilizer, ensuring consistent phytochemical content.

GNH India supplies Hedelix S.A as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Krewel Meuselbach Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Hedelix S.A, containing ivy leaf extract, is used in respiratory disorders that involve mucus hypersecretion and bronchial irritation.

  • Cough: helps loosen and clear airway mucus, reducing cough frequency.
  • Bronchitis: supports airway clearance and may alleviate irritation associated with acute bronchitis.
  • Asthma (mild): may contribute to bronchodilation and reduce bronchial spasm when used as an adjunct under medical supervision.

How It Works

  • The extract of Hedera helix folium contains saponins such as hederacoside C, which exhibit bronchodilatory and anti‑inflammatory activity by modulating calcium influx in airway smooth muscle and inhibiting pro‑inflammatory cytokine release. Additionally, the mucolytic effect is attributed to stimulation of serous gland secretion, facilitating the breakdown and expectoration of viscous mucus.

Side Effects

Adverse reactions to ivy leaf extract are generally mild, but clinicians should be aware of both common and rare events.

Common Side Effects

  • Gastrointestinal discomfort: nausea, abdominal cramps.
  • Skin reactions: mild rash or itching at the oral mucosa.
  • Taste disturbance: bitter or unpleasant taste.
  • Dizziness or light‑headedness.
  • Headache.

Serious or Rare Side Effects

  • Severe allergic reactions: anaphylaxis, angioedema.
  • Hepatic enzyme elevation: potential liver function changes.
  • Bronchospasm: paradoxical tightening of airways.
  • Cardiac arrhythmia: rare reports of rhythm disturbances.

Precautions & Warnings

When considering ivy leaf extract, several safety measures should be observed.

  • Pregnancy: safety not established; avoid use unless clearly indicated.
  • Breastfeeding: caution advised due to limited data on excretion in milk.
  • Children: use only under pediatric supervision and appropriate dosing.
  • Liver disease: monitor hepatic function during therapy.
  • Concomitant medications: review for potential interactions before initiating.
  • Store at ambient temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Ivy leaf extract may influence the activity of certain drugs; interactions are categorized by clinical relevance.

Major Interactions (Avoid)

  • Beta‑adrenergic antagonists: may diminish bronchodilatory benefit.
  • Anticoagulants/antiplatelet agents: potential additive effect on bleeding risk.

Moderate Interactions (Monitor Closely)

  • Cough suppressants (e.g., dextromethorphan): may mask therapeutic effect.
  • Other herbal expectorants: additive mucolytic activity could cause gastrointestinal upset.
  • Bronchodilators (e.g., salbutamol): monitor for enhanced response or tachyphylaxis.

Frequently Asked Questions

Hedelix S.A is a liquid herbal preparation that contains ivy leaf extract. It is used to support respiratory health, particularly to help loosen mucus and ease symptoms of cough, bronchitis, and mild asthma when prescribed by a healthcare professional.

The extract contains saponins such as hederacoside C, which act on airway smooth muscle to promote bronchodilation and reduce inflammation. It also stimulates serous gland secretion, producing a mucolytic effect that helps break down thick mucus for easier expectoration.

The appropriate dose of Hedelix S.A is determined by the prescribing clinician based on the individual’s age, condition severity, and overall health status. Patients should follow the specific instructions provided by their healthcare provider.

Safety data for ivy leaf extract in pregnancy and lactation are limited. It is generally recommended to avoid use during pregnancy and to exercise caution while breastfeeding unless the benefit outweighs potential risk and a physician advises otherwise.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other herbal expectorants, ivy leaf extract is distinguished by its standardized saponin content, which provides both bronchodilatory and mucolytic actions. While many herbal remedies rely solely on soothing properties, Hedelix S.A offers a dual mechanism that may be advantageous in managing mucus‑related respiratory conditions.

Hedelix S.A should be stored at ambient temperature, below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and retain it in the original packaging to maintain product stability.

The product is taken orally as a liquid extract. The prescribed volume is measured using the supplied dropper or calibrated spoon and swallowed, usually with water, according to the dosing schedule set by the prescriber.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, bronchospasm, and potential liver enzyme elevations. Patients should seek immediate medical attention if they experience difficulty breathing, swelling of the face or throat, or signs of liver dysfunction.

Individuals with known hypersensitivity to ivy leaf or any component of the formulation should avoid Hedelix S.A. It is also contraindicated in patients with severe liver disease, uncontrolled asthma, or those taking medications that may interact significantly without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.